These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37433737)

  • 1. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
    Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
    BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
    Silvain J; Cayla G; Beygui F; Range G; Lattuca B; Collet JP; Dillinger JG; Boueri Z; Brunel P; Pouillot C; Boccara F; Christiaens L; Labeque JN; Lhermusier T; Georges JL; Bellemain-Appaix A; Le Breton H; Hauguel-Moreau M; Saint-Etienne C; Caussin C; Jourda F; Motovska Z; Guedeney P; El Kasty M; Laredo M; Dumaine R; Ducrocq G; Vicaut E; Montalescot G;
    Am Heart J; 2020 Jul; 225():27-37. PubMed ID: 32473356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural myocardial infarction and injury in elective coronary stenting.
    Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G;
    Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ
    Eur Heart J; 2021 Jul; 42(27):2630-2642. PubMed ID: 34059914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    Räber L; Ueki Y; Otsuka T; Losdat S; Häner JD; Lonborg J; Fahrni G; Iglesias JF; van Geuns RJ; Ondracek AS; Radu Juul Jensen MD; Zanchin C; Stortecky S; Spirk D; Siontis GCM; Saleh L; Matter CM; Daemen J; Mach F; Heg D; Windecker S; Engstrøm T; Lang IM; Koskinas KC;
    JAMA; 2022 May; 327(18):1771-1781. PubMed ID: 35368058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
    Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
    Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773).
    Kołtowski Ł; Aradi D; Huczek Z; Tomaniak M; Sibbing D; Filipiak KJ; Kochman J; Balsam P; Opolski G
    Kardiol Pol; 2016; 74(4):372-9. PubMed ID: 26365936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
    Otake H; Sugizaki Y; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Kawamori H; Shinke T; Hirata KI
    J Cardiol; 2019 Mar; 73(3):228-232. PubMed ID: 30579806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
    Ray KK; Colhoun HM; Szarek M; Baccara-Dinet M; Bhatt DL; Bittner VA; Budaj AJ; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Loizeau V; Lopes RD; Moryusef A; Murin J; Pordy R; Ristic AD; Roe MT; Tuñón J; White HD; Zeiher AM; Schwartz GG; Steg PG;
    Lancet Diabetes Endocrinol; 2019 Aug; 7(8):618-628. PubMed ID: 31272931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Perioperative Use of Evolocumab in Myocardial Infarction Patients: Study Protocol for a Multicentre Randomized Controlled Trial.
    Luan Y; Wang M; Zhao L; Xu T; Fu G; Zhang W
    Adv Ther; 2021 Apr; 38(4):1801-1810. PubMed ID: 33638801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
    Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.
    Botelho FE; Flumignan RL; Shiomatsu GY; de Castro-Santos G; Cacione DG; Leite JO; Baptista-Silva JC
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD014920. PubMed ID: 38958136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of remote ischaemic preconditioning on myocardial injury after major abdominal surgery in patients at high risk for cardiovascular adverse events in China (RIPC-MAS): protocol for a randomised, sham-controlled, observer-blinded trial.
    Wang F; Liang CJ; Shi JK; Huang QS; Nassirou BM; Wang X; Jin SQ; Zhao Y
    BMJ Open; 2023 Jun; 13(6):e073038. PubMed ID: 37355267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study).
    Wang YW; Xu J; Ma L; Hu H; Chen HW; Hua JS; Kong XY; Li D; Li LW; Pan JY; Wu J
    BMJ Open; 2024 Jul; 14(7):e083730. PubMed ID: 39009458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.
    Silvain J; Zeitouni M; Paradies V; Zheng HL; Ndrepepa G; Cavallini C; Feldman DN; Sharma SK; Mehilli J; Gili S; Barbato E; Tarantini G; Ooi SY; von Birgelen C; Jaffe AS; Thygesen K; Montalescot G; Bulluck H; Hausenloy DJ
    Eur Heart J; 2021 Jan; 42(4):323-334. PubMed ID: 33257958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
    Ueki Y; Otsuka T; Bär S; Koskinas KC; Heg D; Häner J; Siontis GCM; Praz F; Hunziker L; Lanz J; Stortecky S; Pilgrim T; Losdat S; Windecker S; Räber L
    J Am Coll Cardiol; 2022 Feb; 79(6):513-526. PubMed ID: 35144742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
    Zhang F; Dong L; Ge J
    Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.